Charlotta Otter - Concepedia

Concepedia

Author

Charlotta Otter

AstraZeneca (Sweden)

Also Known As

Charlotta A. Otter, Charlotta Otter

16

Publications

1.1K

Citations

12

H-Index

31

Concepts

All Affiliations

AstraZeneca (Sweden)Karolinska Institutet Karolinska University Hospital AstraZeneca (United Kingdom)

CO

About

Charlotta Otter is an author at AstraZeneca (Sweden) specializing in medicine, biochemistry, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	487
2	Biochemistry	8	8	476
3	Natural Sciences	4	4	302
4	Cell Biology	1	1	80
5	Hepatology	1	1	67

Charlotta Otter

×

13

Publications

1.1K

Citations

12

H-Index

	Year	Citations
COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM Anna Westlind-Johnsson, Sarah Malmebo, Anna L.V. Johansson, Drug Metabolism and Disposition	2003	257
Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43 Anna Westlind, Sarah Malmebo, Inger Johansson, Biochemical and Biophysical Research Communications BiochemistryNatural SciencesGeneticsTissue DistributionMolecular Biology	2001	179
Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population Eleni Aklillu, Mikael Oscarson, Mats Hidestrand, Molecular Pharmacology	2002	133
Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research Collen Masimirembwa, Charlotta Otter, Mikael Berg, Drug Metabolism and Disposition	1999	107
CYP3A4, CYP3A5, and MDR1 in Human Small and Large Intestinal Cell Llines Suitable for Drug Transport Studies Helena Engman, Hans Lennernäs, Jan Taipalensuu, Journal of Pharmaceutical Sciences Molecular PharmacologyDrug Transport StudiesGastrointestinal PharmacologyMedicineHuman Small	2001	80
Arginines 97 and 108 in CYP2C9 Are Important Determinants of the Catalytic Function Marianne Ridderström, Collen Masimirembwa, Susanne Trump-Kallmeyer, Biochemical and Biophysical Research Communications Catalytic FunctionBiochemistryNatural SciencesMolecular BiologyReaction Intermediate	2000	69
Evaluation of Human Liver Slices and Reporter Gene Assays as Systems for Predicting the Cytochrome P450 Induction Potential of Drugs in Vivo in Humans Kajsa P. Persson, Susanne Ekehed, Charlotta Otter, Pharmaceutical Research Human Liver SlicesHepatologyBiochemistryMedicineLiver Physiology	2005	67
Characterization and Functional Analysis of Two Common Human Cytochrome P450 1B1 Variants Roman A. McLellan, Mikael Oscarson, Mats Hidestrand, Archives of Biochemistry and Biophysics Molecular PharmacologyBiochemistryMedicineGeneticsBiochemical Genetics	2000	55
Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[<i>a</i>]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[<i>a</i>]pyrene Eleni Aklillu, Steinar Øvrebø, Ingrid V. Botnen, Cancer Research	2005	55
Cytochrome P 450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells Tashinga E. Bapiro, Tommy B. Andersson, Charlotta Otter, European Journal of Clinical Pharmacology Cytochrome P 450Pharmacological StudyBiochemistryAntiparasitic AgentMedicine	2002	40

Page 1